Stem-cell therapies · Regenerative medicine · Intractable diseases
NatureCell
A biotech researching stem-cell regenerative medicine, developing stem-cell therapies for intractable diseases such as osteoarthritis. KOSDAQ large-cap constituent. Baseline node ahead of value-chain research; promoted to a full node once AI question demand is observed.
Business categories Pharmaceuticals & Biotechnology · Biopharma & Life Sciences · primary
Other companies in the same category
- Pharmaceuticals & Biotechnology: Alnylam Pharmaceuticals · Regeneron Pharmaceuticals · Moderna · AbbVie · Lilly (Eli)
007390.KQ Updated Jul 11, 2026 2 AI consumers· 2 recurring
Annual return · 2026-10-08'21+66.3%'22-8.5%'23-43.4%'24+135.8%'25+39.8%YTD-2.8%
Money in ▸·
NatureCell
▸ Money out·
Financials & Segments
- Segments · Stem-cell therapeutics · Cosmetics/health food
Revenue from
No refined links yet.
Pays to
No refined links yet.